Zhiyong Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhiyong Zhao has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
E. Albert Reece
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD
21 shared publicationsRichard L. Eckert
Department of Obstetrics, Gynecology, and Reproductive Sciences, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA
6 shared publicationsYing-King Wu
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland
6 shared publicationsYuanning Cao
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA
6 shared publications- Scott A. Rivkees
Yale Child Health Research Center, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
5 shared publications Kenneth M. Weiss
Department of Anthropology, Pennsylvania State University, University Park, PA 16802, USA
4 shared publications
Latest Publications
- Open Access
- 17 October 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 77, 102881
Development of fully automated models for staging liver fibrosis using non-contrast MRI and artificial intelligence: a retrospective multicenter study
- 17 October 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 77, 102881
Open AccessDevelopment of fully automated models for staging liver fibrosis using non-contrast MRI and artificial intelligence: a retrospective multicenter study
- 1 August 2018
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 219 (2) , 197.e1-197.e8
Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice
- 1 August 2018
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 219 (2) , 197.e1-197.e8
Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice
- Open Access
- 11 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-8
Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy
Diabetes mellitus in early pregnancy can cause neural tube defects (NTDs) in embryos by perturbing protein activity, causing cellular stress, and increasing programmed cell death (apoptosis) in the tissues required for neurulation. Hyperglycemia augments a branch pathway in glycolysis, the hexosamine biosynthetic pathway (HBP), to increase uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc). GlcNAc can be added to proteins by O-GlcNAc transferase (OGT) to regulate protein activity. In the embryos of diabetic mice, OGT is highly activated in association with increases in global protein O-GlcNAcylation. In neural stem cells in vitro, high glucose elevates O-GlcNAcylation and reactive oxygen species, but the elevations can be suppressed by an OGT inhibitor. Inhibition of OGT in diabetic pregnant mice in vivo decreases NTD rate in the embryos. This effect is associated with reduction in global O-GlcNAcylation, alleviation of intracellular stress, and decreases in apoptosis in the embryos. These suggest that OGT plays an important role in diabetic embryopathy via increasing protein O-GlcNAcylation, and that inhibiting OGT could be a candidate approach to prevent birth defects in diabetic pregnancies.
- 11 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-8
Open AccessImpact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy
Diabetes mellitus in early pregnancy can cause neural tube defects (NTDs) in embryos by perturbing protein activity, causing cellular stress, and increasing programmed cell death (apoptosis) in the tissues required for neurulation. Hyperglycemia augments a branch pathway in glycolysis, the hexosamine biosynthetic pathway (HBP), to increase uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc). GlcNAc can be added to proteins by O-GlcNAc transferase (OGT) to regulate protein activity. In the embryos of diabetic mice, OGT is highly activated in association with increases in global protein O-GlcNAcylation. In neural stem cells in vitro, high glucose elevates O-GlcNAcylation and reactive oxygen species, but the elevations can be suppressed by an OGT inhibitor. Inhibition of OGT in diabetic pregnant mice in vivo decreases NTD rate in the embryos. This effect is associated with reduction in global O-GlcNAcylation, alleviation of intracellular stress, and decreases in apoptosis in the embryos. These suggest that OGT plays an important role in diabetic embryopathy via increasing protein O-GlcNAcylation, and that inhibiting OGT could be a candidate approach to prevent birth defects in diabetic pregnancies.
- 4 July 2017
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 33 (4) , 425-427
Traumatic bifrontoparietal extradural hematomas with detachment of superior sagittal sinus: a case report and review of the literature
A 45-year-old man suffered bifrontoparietal extradural hematoma resulting from head injury, which cause superior sagittal sinus detachment from its subperiosteal loggia. We present the patient who was treated by early surgical evacuation of the hematoma with an excellent outcome and we also perform a review of the current literature.
- 4 July 2017
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 33 (4) , 425-427
Traumatic bifrontoparietal extradural hematomas with detachment of superior sagittal sinus: a case report and review of the literature
A 45-year-old man suffered bifrontoparietal extradural hematoma resulting from head injury, which cause superior sagittal sinus detachment from its subperiosteal loggia. We present the patient who was treated by early surgical evacuation of the hematoma with an excellent outcome and we also perform a review of the current literature.
- 10 April 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (17) , 4489-4494
Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects
Significance: Neural tube defects in infants of women with diabetes are associated with disrupted protein folding and increased programmed cell death in embryonic cells. Misfolded proteins are ubiquitinylated and form aggregates that contain the neurodegenerative disease-associated proteins α-Synuclein, Parkin, and Huntingtin (Htt). Aggregation of Htt leads to formation of a Hip1–Hippi–Caspase-8 complex to activate Caspase-8. Treatment with chemical chaperones alleviates protein aggregation and decreases neural tube defects in the embryos of diabetic mice. Targeting misfolded proteins could be a potential approach to preventing birth defects in diabetic pregnancies.
- 10 April 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (17) , 4489-4494
Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects
Significance: Neural tube defects in infants of women with diabetes are associated with disrupted protein folding and increased programmed cell death in embryonic cells. Misfolded proteins are ubiquitinylated and form aggregates that contain the neurodegenerative disease-associated proteins α-Synuclein, Parkin, and Huntingtin (Htt). Aggregation of Htt leads to formation of a Hip1–Hippi–Caspase-8 complex to activate Caspase-8. Treatment with chemical chaperones alleviates protein aggregation and decreases neural tube defects in the embryos of diabetic mice. Targeting misfolded proteins could be a potential approach to preventing birth defects in diabetic pregnancies.
- Open Access
- 18 February 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 21491
Amelioration of intracellular stress and reduction of neural tube defects in embryos of diabetic mice by phytochemical quercetin
Diabetes mellitus in early pregnancy causes birth defects, including neural tube defects (NTDs). Hyperglycemia increases production of nitric oxide (NO) through NO synthase 2 (Nos2) and reactive oxygen species (ROS), generating nitrosative and oxidative stress conditions in the embryo. The present study aimed to target nitrosative stress using a naturally occurring Nos2 inhibitor, quercetin, to prevent NTDs in the embryos of diabetic mice. Daily administration of quercetin to diabetic pregnant mice during the hyperglycemia-susceptible period of organogenesis significantly reduced NTDs and cell apoptosis in the embryos, compared with those of vehicle-treated diabetic pregnant mice. Using HPLC-coupled ESI-MS/MS, quercetin metabolites, including methylated and sulfonylated derivatives, were detected in the conceptuses. The methylated metabolite, 3-O-methylquercetin, was shown to reduce ROS level in embryonic stem cells cultured in high glucose. Quercetin treatment decreased the levels of Nos2 expression, protein nitrosylation and protein nitration, alleviating nitrosative stress. Quercetin increased the expression of superoxide dismutase 1 and 2 and reduced the levels of oxidative stress markers. Expression of genes of redox regulating enzymes and DNA damage repair factors was upregulated. Our study demonstrates that quercetin ameliorates intracellular stresses, regulates gene expression and reduces embryonic malformations in diabetic pregnancy.
- 18 February 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 21491
Open AccessAmelioration of intracellular stress and reduction of neural tube defects in embryos of diabetic mice by phytochemical quercetin
Diabetes mellitus in early pregnancy causes birth defects, including neural tube defects (NTDs). Hyperglycemia increases production of nitric oxide (NO) through NO synthase 2 (Nos2) and reactive oxygen species (ROS), generating nitrosative and oxidative stress conditions in the embryo. The present study aimed to target nitrosative stress using a naturally occurring Nos2 inhibitor, quercetin, to prevent NTDs in the embryos of diabetic mice. Daily administration of quercetin to diabetic pregnant mice during the hyperglycemia-susceptible period of organogenesis significantly reduced NTDs and cell apoptosis in the embryos, compared with those of vehicle-treated diabetic pregnant mice. Using HPLC-coupled ESI-MS/MS, quercetin metabolites, including methylated and sulfonylated derivatives, were detected in the conceptuses. The methylated metabolite, 3-O-methylquercetin, was shown to reduce ROS level in embryonic stem cells cultured in high glucose. Quercetin treatment decreased the levels of Nos2 expression, protein nitrosylation and protein nitration, alleviating nitrosative stress. Quercetin increased the expression of superoxide dismutase 1 and 2 and reduced the levels of oxidative stress markers. Expression of genes of redox regulating enzymes and DNA damage repair factors was upregulated. Our study demonstrates that quercetin ameliorates intracellular stresses, regulates gene expression and reduces embryonic malformations in diabetic pregnancy.
- 1 February 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 470 (3) , 599-605
Identification of novel cell survival regulation in diabetic embryopathy via phospholipidomic profiling
- 1 February 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 470 (3) , 599-605
Identification of novel cell survival regulation in diabetic embryopathy via phospholipidomic profiling
- 17 September 2014
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 101 (5) , 364-370
TGFβ and Wnt in Cardiac Outflow Tract Defects in Offspring of Diabetic Pregnancies
BACKGROUND: Diabetes mellitus in pregnancy causes defects in infant heart, including the outflow tracts (OFTs). Development of the aorta and pulmonary artery, which are derived from the common OFT in the embryo, is regulated by the transforming growth factor β (TGFβ) and Wnt families, and can be perturbed by hyperglycemia‐generated intracellular stress conditions. However, the underlying cellular and molecular mechanisms remain to be delineated.METHODS: Female mice were induced diabetic with streptozotocin. Embryonic and fetal OFTs were examined morphologically and histologically. Cell proliferation was assessed using 5’‐bromo‐2’‐deoxyuridine incorporation assay. Oxidative and endoplasmic reticulum (ER) stress markers and TGFβ factors were detected using immunohistochemistry. The expression of genes in the Wnt‐signaling system was assessed using real‐time reverse transcription polymerase chain reaction array. The role of activin‐A in cell proliferation was addressed by treating embryos cultured in high glucose with activin‐A.RESULTS: Maternal diabetes caused complex abnormalities in the OFTs, including aortic and pulmonary stenosis and persistent truncus arteriosus. The development of the endocardial cushions was suppressed, manifested with insufficient cellularization of the tissues. Cell proliferation was significantly decreased under oxidative and ER stress conditions. The expression of genes in the Wnt signaling was significantly altered. Activin‐A and Smad3 were found to be expressed in the OFT. Treatment with activin‐A rescued cell proliferation in the endocardial cushions.CONCLUSIONS: Maternal diabetes generates oxidative and ER stress conditions, suppresses TGFβ and Wnt signaling, inhibits cell proliferation and cellularization of the endocardial cushions, leading to OFT septal defects. Activin‐A plays a role in hyperglycemia‐suppressed proliferation of the endocardial cells
- 17 September 2014
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 101 (5) , 364-370
TGFβ and Wnt in Cardiac Outflow Tract Defects in Offspring of Diabetic Pregnancies
BACKGROUND: Diabetes mellitus in pregnancy causes defects in infant heart, including the outflow tracts (OFTs). Development of the aorta and pulmonary artery, which are derived from the common OFT in the embryo, is regulated by the transforming growth factor β (TGFβ) and Wnt families, and can be perturbed by hyperglycemia‐generated intracellular stress conditions. However, the underlying cellular and molecular mechanisms remain to be delineated.METHODS: Female mice were induced diabetic with streptozotocin. Embryonic and fetal OFTs were examined morphologically and histologically. Cell proliferation was assessed using 5’‐bromo‐2’‐deoxyuridine incorporation assay. Oxidative and endoplasmic reticulum (ER) stress markers and TGFβ factors were detected using immunohistochemistry. The expression of genes in the Wnt‐signaling system was assessed using real‐time reverse transcription polymerase chain reaction array. The role of activin‐A in cell proliferation was addressed by treating embryos cultured in high glucose with activin‐A.RESULTS: Maternal diabetes caused complex abnormalities in the OFTs, including aortic and pulmonary stenosis and persistent truncus arteriosus. The development of the endocardial cushions was suppressed, manifested with insufficient cellularization of the tissues. Cell proliferation was significantly decreased under oxidative and ER stress conditions. The expression of genes in the Wnt signaling was significantly altered. Activin‐A and Smad3 were found to be expressed in the OFT. Treatment with activin‐A rescued cell proliferation in the endocardial cushions.CONCLUSIONS: Maternal diabetes generates oxidative and ER stress conditions, suppresses TGFβ and Wnt signaling, inhibits cell proliferation and cellularization of the endocardial cushions, leading to OFT septal defects. Activin‐A plays a role in hyperglycemia‐suppressed proliferation of the endocardial cells
- 1 June 2013
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 33 (2) , 207-233
New Concepts in Diabetic Embryopathy
- 1 June 2013
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 33 (2) , 207-233
New Concepts in Diabetic Embryopathy
- 28 May 2013
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 98 (3) , 260-267
Activin-A in Diabetes-Induced Cardiac Malformations in Embryos
BACKGROUND Heart defects are the most common abnormalities in infants of diabetic mothers. Cardiac malformation is associated with altered expression of the genes in the transforming growth factor β system, including inhibin βA, which forms activin‐A as a homodimer and functions through its effectors, Smad2 and Smad3. This study aimed to investigate the role of activin‐A in diabetes‐induced cardiac malformations. METHODS Diabetes mellitus in female mice (C57BL/6J) was induced via intravenous injection of streptozotocin. The expression of inhibin βA protein and phosphorylation of Smad2 and Smad3 in the embryonic hearts were examined using immunohistochemical, in situ proximity ligation, and immunoblot assays. Embryos and endocardial cushions of nondiabetic mice were cultured in a high concentration of glucose and treated with activin‐A. Mitosis was examined using BrdU incorporation assay and immunohistochemistry of phosphorylated histone H3. Migration of the endocardial cells was assessed using a collagen‐based cell migration assay. RESULTS The levels of inhibin βA expression and Smad2 and Smad3 activation were significantly reduced by maternal diabetes. Treatment with activin‐A significantly increased cell proliferation in the myocardium and migration of endocardial cells, compared with those in vehicle‐treated high glucose group, to the level in the euglycemic control group. CONCLUSIONS Maternal diabetes suppresses the expression of inhibin βA protein, as well as the activation of Smad2 and Smad3. Activin‐A rescues cell proliferation in the myocardium and migration of the endocardial cells suppressed by hyperglycemia. The activin‐Smad2/3 signaling system appears to play a role in cardiac malformation in diabetic embryopathy. Birth Defects Res (Part B) 98:260–267, 2013.
- 28 May 2013
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 98 (3) , 260-267
Activin-A in Diabetes-Induced Cardiac Malformations in Embryos
BACKGROUND Heart defects are the most common abnormalities in infants of diabetic mothers. Cardiac malformation is associated with altered expression of the genes in the transforming growth factor β system, including inhibin βA, which forms activin‐A as a homodimer and functions through its effectors, Smad2 and Smad3. This study aimed to investigate the role of activin‐A in diabetes‐induced cardiac malformations. METHODS Diabetes mellitus in female mice (C57BL/6J) was induced via intravenous injection of streptozotocin. The expression of inhibin βA protein and phosphorylation of Smad2 and Smad3 in the embryonic hearts were examined using immunohistochemical, in situ proximity ligation, and immunoblot assays. Embryos and endocardial cushions of nondiabetic mice were cultured in a high concentration of glucose and treated with activin‐A. Mitosis was examined using BrdU incorporation assay and immunohistochemistry of phosphorylated histone H3. Migration of the endocardial cells was assessed using a collagen‐based cell migration assay. RESULTS The levels of inhibin βA expression and Smad2 and Smad3 activation were significantly reduced by maternal diabetes. Treatment with activin‐A significantly increased cell proliferation in the myocardium and migration of endocardial cells, compared with those in vehicle‐treated high glucose group, to the level in the euglycemic control group. CONCLUSIONS Maternal diabetes suppresses the expression of inhibin βA protein, as well as the activation of Smad2 and Smad3. Activin‐A rescues cell proliferation in the myocardium and migration of the endocardial cells suppressed by hyperglycemia. The activin‐Smad2/3 signaling system appears to play a role in cardiac malformation in diabetic embryopathy. Birth Defects Res (Part B) 98:260–267, 2013.